LAHORE: Citi Pharma Limited has successfully conducted its Extraordinary General Meeting (EGM) where shareholders adopted key resolutions, as required under Clause 5.6.9(b) of the Pakistan Stock Exchange Regulations. The meeting, which took place on Wednesday, July 8, 2026, at 2:00 p.m., was held at the company’s head office located at 588-Q, Johar Town, Lahore.

The resolutions were adopted in compliance with an order from the Honourable Lahore High Court, Lahore. Shareholders gathered to discuss and approve matters crucial to the company's operations and future directives.

According to information available from the Pakistan Stock Exchange (PSX), the resolutions are part of the regulatory requirements ensuring transparency and corporate governance within the market. The resolutions are expected to influence the strategic direction of Citi Pharma Limited.

This announcement was made public on July 9, 2026, highlighting the company’s adherence to legal protocols and its commitment to maintaining shareholder trust and regulatory compliance. The resolutions and the meeting itself demonstrate Citi Pharma's proactive approach in aligning with judicial and stock exchange mandates.

Citi Pharma Limited, operating within the pharmaceutical sector, continues to focus on its strategic goals while ensuring adherence to legal and regulatory frameworks set forth by judicial authorities and the PSX.